[Influence of time-dose-relationships in therapeutic nuclear medicine applications on biological effectiveness of irradiation: consequences for dosimetry].
OBJECTIVE
The biological effectiveness of irradiation is influenced not only by the total dose but also the rate at which this dose is administered. Tolerance dose estimates from external radiation therapy with a conventional fractionation protocol require adaptation for application in targeted radionuclide therapy.


METHODS
The linear-quadratic model allows for calculation of the biologically effective dose (BED) and takes into consideration tissue specific factors (recovery capacity) as well as dose rate effects (recovery kinetics). It can be applied in radionuclide therapy as well. For relevant therapeutic radionuclides (e. g. (188)Re, (90)Y, (177)Lu, and (131)I), the effect of different physical decay times and variable biological half-lives on BED was calculated for several organs.


RESULTS
BED is markedly increased using (188)Re compared to longer-lived radionuclides. The effect is dose-dependent and tissue-specific, resulting, for example, in higher effects on the kidneys compared to bone marrow. Therefore, in unfavourable conditions (e. g. reduced recovery capacity due to concomitant diseases or previous therapy), the BED may exceed organ dose tolerance.


CONCLUSIONS
Time-dose-relationships have to be taken into consideration by the calculation of BED for internal radionuclide therapy. The biological effectiveness depends on dose- and tissue-specific factors and is much more pronounced in (188)Re than in (90)Y and other longer living radionuclides. Determination of organ tolerance dose values should take into account these radiobiological differences, since it is currently not considered in dosimetry programs.
Klinik und Poliklinik für Nuklearmedizin, Universitätsklinikum Carl Gustav Carus, Technische Universitat Dresden. Liane.Oehme@uniklinikum-dresden.de
L
L
Oehme
W
W
Dörr
P
P
Wust
J
J
Kotzerke
D019583:Dose Fractionation, Radiation; D004307:Dose-Response Relationship, Radiation; D006207:Half-Life; D006801:Humans; D007668:Kidney / Q000473:pathology / Q000528:radiation effects; D009683:Nuclear Medicine / Q000379:methods / Q000639:trends; D011836:Radiation Tolerance; D011868:Radioisotopes / Q000737:chemistry / Q000627:therapeutic use; D011879:Radiotherapy Dosage
D011868:Radioisotopes
Einfluss der Dosisleistung nuklearmedizinischer Therapie auf die biologische Strahlenwirkung. Konsequenzen für die Dosimetrie.